Swissray developed the world’s first FDA-approved (US Food & Drug Administration) low-dose diagnostics X-ray system and has achieved major accomplishments in digital X-ray system technology. Its full range of products, under the Swissray brand, has also received approval by China Food and Drug Administration (CFDA). The company is actively developing business opportunities in the Asia Pacific region and other emerging markets around the world.

Delta’s chairman, Mr. Yancey Hai, said, “Delta is focused on strengthening organizational growth and investing in new sectors; and the healthcare device field is one of them. Swissray has been a remarkable customer of our medical power business division and both firms have already built an excellent collaborative relationship over the years.”

“In fact, we are jointly developing a baby X-ray system and plan to finish the project in 2016. Following this investment, significant synergies and enhanced global business opportunities will result from aligning Delta’s state-of-the-art R&D and manufacturing capabilities with Swissray’s brand value, channels and business development resources.”